Glutathione monoesters in which the carboxyl group of the glycine residue is esterified were previously found, in contrast to glutathione itself, to be effectively transported into various types of cells and to be converted intracellularly into glutathione. Glutathione monoesters are thus useful for prevention of oxidative stress, certain toxicities, and for treatment of glutathione deficiency. Glutathione diethyl ester is rapidly split to the glutathione monoethyl ester by mouse plasma glutathione diester a-esterase activity. Thus, as expected, glutathione mono-and diesters have similar effects on cellular glutathione levels in mice. However, human plasma lacks glutathione diester a-esterase; thus, it became of interest to compare the transport properties of glutathione mono-and diesters in human cells. We found that human cells (erythrocytes, peripheral blood mononuclear cells, fibroblasts, ovarian tumor ceDls, and purified T cells) transport glutathione diethyl ester much more effectively than the corresponding monoethyl (glycyl) ester. Human cells rapidly convert glutathione diethyl ester to the monoester, whose intracellular levels rise to levels that are significantly higher than levels found after application of the monoester to the cells. High levels of the monoester provide the cells with a means of producing glutathione over a period of time. We conclude that glutathione diethyl ester is highly effective as a delivery agent for glutathione monoester, and thus for glutathione, in human cells and therefore could serve to decrease oxidative stress and toxicity. Hamster (and certain other animals) also lack plasma glutathione diester a-esterase and therefore would be suitable animal models.
serve to decrease oxidative stress and toxicity. Hamster (and certain other animals) also lack plasma glutathione diester a-esterase and therefore would be suitable animal models.
Previously reported toxicity of certain glutathione ester preparations appears to reflect the presence of impurities rather than effects of the esters.
Glutathione (GSH) is not efficiently transported into most animal cells (1) . Previous studies have shown that monoesters of GSH in which the glycine carboxyl group is esterified are highly efficient delivery agents for GSH (2) (3) (4) (5) . Thus, the monoethyl (glycyl) ester of GSH is well transported into many animal tissues (e.g., liver, kidney, pancreas, spleen, heart, lung, skeletal muscle, lymphocytes) and hydrolyzed intraceliularly to GSH. GSH monoesters are more effective than GSH and various other GSH derivatives in increasing cellular GSH levels (2) .
Recent experiments in our laboratory in which suspensions ofhuman erythrocytes were incubated with GSH monoesters showed that metal ion contamination leads to a marked decrease in the level of total cellular thiols. In the course of these studies, we observed that certain GSH monoethyl ester preparations that contained 10-15% of the corresponding diester were unexpectedly very effective in increasing cellular thiol levels. This led us to reexamine GSH diethyl ester as a potential cellular GSH delivery compound. An improved method for preparing this compound in high purity has been devised. Earlier evidence suggested that GSH dimethyl ester
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. might be toxic to mice, but toxicity was not observed in the present studies in which GSH diethyl ester was given to mice and to hamsters. GSH diethyl ester is rapidly converted into GSH monoethyl (glycyl) ester by esterase activity present in rat and mouse blood plasma. GSH diethyl ester is therefore no more useful than the monoester as a GSH delivery agent in these species; indeed, we observed that injection of GSH diethyl ester and of GSH monoethyl (glycyl) ester into mice led to similar increases in tissue GSH levels. However, we found that human blood plasma does not have GSH diester a-esterase activity. Thus, GSH diethyl ester would be expected to be relatively stable in human plasma and thus serve as an efficient cellular GSH delivery agent because of its increased hydrophobicity. We (4, 6) .
Glutathione Diethyl Ester. GSH (5 g) was added to an ice-cold solution of 100 ml of ethanol containing 5.6 ml of concentrated H2SO4. The slurry was stirred briefly at 0°C until the GSH dissolved. The reaction was allowed to stand (0-5°C) and was about 70% complete after 3-7 days. Cold diethyl ether (10 vol) (8) . GSH monoethyl (glycyl) ester has been characterized by NMR (3, 19) .
Methods. Cell culture. Human skin fibroblast line CCD-42SK cells (American Type Culture Collection) were maintained (37°C; 95% air/5% C02) in Dulbecco's minimal essential medium (DMEM) (containing sodium pyruvate) supplemented with 10% (vol/vol) fetal calf serum (FCS) and 1% penicillin/streptomycin. The FCS used here did not exhibit GSH diester a-esterase activity. Human ovarian tumor cell lines A2780, 1A9 (a clonal variant of A2780), and 1A9/4E (a cisplatin-resistant variant of 1A9) (9) were maintained (37°C; 95% air/5% C02) in RPMI 1640 supplemented with 10% FCS, 1% penicillin/streptomycin, and 0.1% insulin. Peripheral blood mononuclear cells (PBM) (and T cells) were maintained (37°C; 95% air/5% C02) in RPMI 1640 supplemented with 5% FCS and 1% penicillin/streptomycin.
T cells, PBM, fibroblasts, and ovarian cell lysates. Cells were treated with 4.31% 5-sulfosalicylic acid (SSA) containing 0.5 mM diethylenetriamine pentaacetic acid (DTPA), allowed to stand for 20 min on ice, and then lysed by scraping or freezing/thawing. Plasma samples. Blood was mixed with 50 ,ul of 0.5 M EDTA (pH 7) as anticoagulant and immediately centrifuged (10,000 x g for 1.5 min). For thiol analysis, plasma (200 ,ul) was immediately treated with 100 ,ul of 10% SSA containing 0.5 mM DTPA, mixed, and centrifuged.
Animal tissues. Hamsters anesthetized by i.p. administration (in saline) ofxylazine (1.4 mg) and ketamine (21 mg) were decapitated and exsanguinated. Tissues were removed, washed briefly in water, blotted, weighed, and homogenized (5 ml/g) with 5% SSA containing 0.5 mM DTPA.
Derivatization for HPLC. Common solutions used in all derivatizations are: 2 M Tris HCl (pH 9 at 21°C) and 0.1 M mBBr in CH3CN (stored in the dark at -20°C when not in use). Samples were treated with Tris followed immediately by mBBr according to Table 1 and placed in the dark; after 20 min, they were treated with glacial acetic acid (to pH 3.9) and then placed at -20°C until analyzed. Standards for each sample type were prepared with the appropriate mixtures.
HPLC analysis ofcellular thiols (10) (11) (12) (13) . Derivatized samples were chromatographed at room temperature at a flow 100% A was used initially followed by a linear gradient to 65% A (35% B) over 25 min, followed by a linear gradient to 100% B over 10 min. The column was washed for 5 min with 100% B and reequilibrated for 8 min with 100% A before the next injection. The retention times for cysteine, GSH, GSH monoester, cysteinylglycine ethyl ester, and GSH diester were 7, 10, 22, 29 and 35 min, respectively. In the studies on metal ions and GSH esters, the total thiol levels of erythrocytes were determined by reaction with DTNB (7). Samples for atomic absorption analysis were prepared in distilled deionized water at concentrations of 30-80 mM.
RESULTS
Transport of GSH Diethyl Ester into Human Cells. When suspensions of human erythrocytes were treated with GSH diethyl ester, there was a rapid increase in the level ofcellular thiols; about equal levels ofGSH diester and GSH monoester were found after 7 min, but the level of GSH monoester increased substantially thereafter with slight increase of the GSH level (Fig. 1 ). In the experiment described in Fig. 2 , human erythrocytes were treated with GSH diester for 7 min; the cells were then quickly centrifuged and resuspended in PBS; the effiux ofthiols was estimated. Efflux ofGSH diester was substantially more rapid (40-to 50-fold) than that of GSH monoester.
Treatment of whole human blood with GSH esters (Table  2) led to appreciable uptake of these by erythrocytes. Interestingly, the cellular levels of GSH monoester were much higher after treatment with GSH diester than after treatment with GSH monoester, and the total levels of thiol after treating with GSH diester were much higher than found after treatment with the monoester. The total thiol levels of the PBM were also much greater after treating with GSH diester than after treating with GSH monoester; the level of GSH was increased more than 4-fold by the diester and about 1.7-fold by the monoester. The data show that both GSH monoester and GSH diester are transported into erythrocytes and PBM ofwhole human blood; GSH diester is more rapidly taken up and is effectively converted intracellularly to GSH monoester. Formation of GSH occurs more rapidly in PBM Similar findings were also obtained in studies in which purified (14) human T cells were studied (Table 3) . Here GSH biosynthesis was inhibited by treatment with buthionine sulfoximine (BSO) (15, 16) . That these cells carry out substantial metabolism of GSH is indicated by the considerable formation of cysteine under these conditions. The uptake of GSH diester by T cells was greater than that of GSH monoester (Table 3) .
Human ovarian tumor cells grown in culture also transported GSH diester more rapidly than the monoester (Table  4) . This was true for two cisplatin-sensitive cell lines (1A9 and A2780) and for a cisplatin-resistant cell line (1A9/4E). The latter exhibited substantially higher initial GSH levels than the sensitive lines as reported (9) . [In the present study the cells were grown to confluence; under these conditions the GSH levels are appreciably lower than found in subconfluent cultures (unpublished findings).]
Studies on a human fibroblast cell line (CCD-42SK) ( Table  5) DTPA) and then centrifuged again. These supernatants were prepared for HPLC analysis. The value obtained at "time zero" (i.e., after the first centrifugation after adding PBS) was subtracted from each subsequent time point (GSH diester, 0.42 mM; GSH monoester, 0 mM). Data are means ± SD (n = 3-6). No efflux of GSH itself was seen.
GSH monoester, and the uptake of the diester was accompanied by substantial formation ofGSH monoester. The level of GSH found after treatment with the diester was 3-fold greater than with the monoester, and there was greater metabolism ofGSH (asjudged by formation ofcysteine) after treatment with the diester.
In the studies reported in Tables 4 and 5 there was some increase ofthe cellular GSH level after incubation ofthe cells in solutions containing GSH; this is -not due to significant transport of GSH but rather to extracellular breakdown of GSH, transport ofthe products, and intracellular synthesis of GSH; this pathway, which occurs in a number of cells, is interrupted by inhibitors of GSH synthesis or GSH breakdown (see ref. 17) .
Plasma GSH Diester a-Esterase Activity. As stated above, plasma from mice and rats contains esterase activity that converts GSH diester to GSH monoester. This was readily demonstrated in vitro by incubating GSH diester with mouse plasma. The mixtures contained 0-40 A4 of mouse plasma, 8 mM GSH diethyl ester, and 16 mM EDTA in PBS (pH 7.2) in a total volume of 400 p1; after incubation at 37°C for 0-15 min, portions were treated with SSA (3.33% final concentration), centrifuged, treated with dithiothreitol, and analyzed by HPLC. Under these conditions, 1 pl ofmouse plasma split 4 nmol of GSH diester per min; activity was linear with time (up to 15 min) and plasma level (1-20 pA). SD (n = 3) . The cells were obtained as described (14) and treated with 5 mM BSO for 16 hr. To 0.9 ml of T cells in PBS (1.5-1.8 x 107 cells) was added 0.3 ml of 80 mM GSH, GSH monoester, or GSH diester (at pH 7). After incubation at 37°C for 7 min, the cells were washed, lysed, and processed for HPLC analysis. Data are means ± SD (n = 5 or 6). *BSO treatment was omitted.
That this reaction occurs in vivo was shown in studies in which mice were injected i.p. with GSH diester (5 mmol/kg of body weight). After 15 min, the blood plasma was obtained; HPLC analysis showed no GSH diester, but there were considerable levels (o1500 ,uM) of GSH monoester. A comparison of the effects of i.p. administration to mice of GSH diester and of GSH monoester (5 mmol/kg) on the levels of GSH in liver and kidney showed essentially no differences.
Studies of human plasma (obtained after treatment of whole blood with heparin or EDTA) and of human serum showed no GSH diester a-esterase activity; a total of nine samples ofplasma or serum from six different individuals was studied. Mixtures ofhuman and mouse serum or plasma gave the expected additive results. Rat plasma was found to exhibit GSH diester a-esterase activity, whereas plasma from hamsters, guinea pigs, rabbits, and sheep did not show this activity. Initial studies on hamsters were carried out in which GSH diethyl ester (5 mmol/kg) was given i.p. After 1 hr, there was a 3-fold increase in the level of GSH in the liver, an increase much greater than that found after giving GSH monoester. These results suggest that the hamster will serve as a convenient animal model for further studies on the in vivo disposition of GSH diester.
Trace Impurities in GSH Ester Preparations. As stated above, we found that incubation of human erythrocyte suspensions with certain preparations of GSH monoethyl ester led to a decrease (16-72%) of the total cellular thiol levels, whereas others led to an increase as reported (2) . Studies in which the erythrocytes were lysed after incubation, treated with dithiothreitol, and then analyzed by HPLC showed that GSH monoester was in all instances transported; however, some ester preparations appeared to contain substance(s) that promoted thiol oxidation. Addition of EDTA or ofDTPA (10 mM) decreased the extent of oxidation appreciably. Since metal ion contamination appeared probable, atomic absorption studies (for Pb, Ni, Cr, Fe, Cu, Al, Mn, and Ti) were carried out, and a correlation was found between the oxidative behavior of ester preparations and their Cu content. Cu levels of 40-110 ppm were invariably associated with oxidation; monoester preparations that had <5 ppm of Cu did not promote oxidation. In a study in which a GSH monoester preparation containing <5 ppm of Cu was incubated for 3 hr with human erythrocytes, the intracellular thiol level increased by about 70%o. When CuSO4 was added to such incubations at levels of 0.5, 1.0, and 2.5 ,uM, the thiol levels increased by 63%, 42%, and 18%, respectively. Addition of 2.5 ,uM Cu2+ to erythrocytes in the absence of GSH monoester did not affect thiol levels. This suggests that GSH monoester may bind Cu2+ and carry it into erythrocytes leading to thiol oxidation. In contrast to these findings with GSH monoester, GSH diester preparations did not promote oxidation of erythrocyte thiols. Thus, treatment of erythrocytes with a preparation of GSH diester that contained 100 ppm of Cu2+ led to a substantial increase of intracellular thiol level which was unaffected by addition of more (100 ppm) Cu2+ as CuS04. Further study of the interaction of GSH esters with Cu2+ and other metal ions would be of interest.
In addition to Cu2+ and other metal ions, the presence of other impurities in GSH ester preparations also needs to be considered. Since the -t-glutamyl bond of GSH is relatively labile, cysteinylglycine ester (or its disulfide) is formed during preparation of GSH diester (see above). Cystinylbisglycine (and probably also its ester) is a potent oxidant (18) esterified as cellular GSH delivery agents (2-5; 17) . The present studies show that GSH diethyl ester, while about equally effective as GSH monoethyl ester when injected into mice, is significantly more effective than the monoester with human cells. The more rapid transport of the diester may probably be ascribed to its greater lipophilicity. It is notable that the diester is rapidly split intracellularly to the monoester, and high levels of the monoester are found intracellularly. The monoester, which is converted to GSH intracellularly, is only slowly exported; thus, the diester serves as a monoester delivery compound, which is "trapped" as monoester within the cells (Fig. 3) . Previous studies showed that administration of monoester leads to increased cellular GSH levels, and the present studies show that application of the diester leads to higher cellular levels of monoester than are achieved by application of the same level of monoester. The high cellular level of monoester achieved after application of the diester would be expected to provide the cell with a means for continually producing GSH over a period of time.
If the uptake of diester occurs by diffusion, its rapid conversion within the cell to the monoester would be expected to favor uptake. The data on efflux of the esters (Fig.  2) indicate that the diester and the monoester can cross the cell membrane in both directions and that this occurs much more rapidly with the diester than with the monoester. Although the findings are consistent with the view that transport of the esters occurs by diffusion, one cannot exclude participation of a transport system (or systems).
These studies suggest that the diester may have significant practical application, for example, in protection against oxidative stress or certain other types of toxicity. However, a potential disadvantage is that 2 mol of ethanol are produced for each mole of GSH formed intracellularly, and this might produce unacceptable toxicity in certain situations. However, it appears that the dose of diester necessary to produce a particular cellular level of GSH is significantly less than that for GSH monoester. It will be important to examine the in vivo effects of the diester in experimental animals such as the hamster, rabbit, and guinea pig. Our initial studies on hamsters showed a 3-fold increase in the level of GSH in the liver after giving an i.p. dose of 5 mmol of diester per kg; this increase is much greater than observed (about 0.7-fold) in similar studies in mice, suggesting that lower doses of diester might be effective in vivo in species (such as humans) that lack plasma GSH diester a-esterase.
We have not observed evidence of toxicity after i.p. injection of the diester into mice or hamsters, but these observations need to be followed up. Many in vivo studies have been carried out in which GSH monoesters were given to mice and other animals without evidence of major toxicity; however, there have been occasional reports of toxicity (2, (20) (21) (22) (23) which we have tentatively ascribed to impurities in the ester preparations used (17 
